Approval · Notice of Compliance 14681 · 2013
ILEVRO: Notice of Compliance 14681
Issued August 22, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14681
- Date
- August 22, 2013
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Nonsteroidal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ILEVRO | 02411393 | Marketed |
Medicinal ingredients
- NEPAFENAC 0.3 PER